Cover Image

Nuclear paraspeckle assembly transcript 1: The long non‐cognized RNA connecting senescence and hepatocellular carcinoma

Fuente: Wiley Open Access

Saved in:

Bibliographic Details
Main Authors:	Yanjun Wu, Han Zhou, Qimin Zhou, Yi Xu
Format:	Artículo Open Access
Published:	Wiley 2024
Subjects:	Clinical and Translational Discovery
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

A snapshot of the role of estrogen‐regulated divergent non‐coding transcripts
by: Barbara Yang, et al.
Published: (2025)

Developing messenger RNA biomarkers: A workflow to characterise and identify transcript target sequences unaffected by alternative splicing for reproducible gene transcript quantification by reverse transcriptase quantitative polymerase chain reaction
by: Bhaja Krushna Padhi, et al.
Published: (2024)

Integrative analyses of single‐cell and bulk RNA sequencing reveal tumour microenvironment features associated with neoadjuvant immunochemotherapy response in oesophageal squamous cell carcinoma
by: Xianxian Wu, et al.
Published: (2025)

Effects of microRNA on the growth and targeted therapy response on lung cancer
by: Mengchen Zhu, et al.
Published: (2024)

Integrating single‐cell RNA sequencing data to decipher heterogeneity and function of macrophages in various organs and diseases
by: Xinjie Xu, et al.
Published: (2024)

Thyroglobulin mRNA ectopic expression was an excellent marker to detect lymph node metastasis for patients with papillary thyroid cancer
by: Wen‐Hua Du, et al.
Published: (2025)

Current advances in the role of classical non‐homologous end joining in hematologic malignancies
by: Pengcheng Liu, et al.
Published: (2025)

Tertiary lymphoid structures: Defining immune subtypes and enabling precision immunotherapy in nasopharyngeal carcinoma
by: Fan Liu, et al.
Published: (2025)

Impact pathway and gene ontology analyses of FOXC2 ‐correlated genes in melanoma reveal a role for the FOXC2 transcription factor in several oncogenic pathways and processes
by: Kristian M. Hargadon, et al.
Published: (2025)

Single‐cell RNA sequencing reveals telocytes subsets of human lung
by: Lihua Dai, et al.
Published: (2024)

A vital step toward targeting lymph node metastasis: Identifying APOE− cells as prognostic drivers in papillary thyroid carcinoma
by: Ling Xiao, et al.
Published: (2025)

Systemic microRNA profiles associated with coronary plaque stability and clinical phenotypes in patients with coronary artery disease
by: Souhir Wassaifi, et al.
Published: (2026)

Astrocytes as central integrators of neural circuit function: Mechanisms and dysregulation in neuropsychiatric disorders
by: Xinyu Liu, et al.
Published: (2026)

Spatial omics accelerate the study of cancer‐associated fibroblasts in non‐small lung cancer
by: Haozhen Liu, et al.
Published: (2024)

Prediction factors and models for chronic kidney disease in type 2 diabetes mellitus: A review of the literature
by: Yan Yang, et al.
Published: (2024)

Sex differences in genomics, immune microenvironment and immunotherapy response in adult grade 4 gliomas
by: Feng Tang, et al.
Published: (2026)

Tumour hepcidin levels as a biomarker for predicting response to immune checkpoint inhibition in advanced non‐small cell lung cancer
by: Yuichiro Suzukawa, et al.
Published: (2026)

Single‐cell sequencing for cancer precision medicine: From mechanism discovery to diagnosis and therapeutics
by: Yue Zhao, et al.
Published: (2026)

Impacts of immune microenvironment on musculoskeletal health
by: Ren Xu
Published: (2024)

DRAM1‐defined autophagy‐JAK‐STAT‐Tregs axis drives immunosuppression and predicts immunotherapy response in pan‐cancer
by: Jinchun Wu, et al.
Published: (2026)

Patients with symptoms of haemolytic anaemia and thrombocytopenia revealed by genetic testing as sitosterolemia
by: Mengjia Qian, et al.
Published: (2025)

Mesenchymal stem cell therapy for ulcerative colitis: Opportunities and challenges in precision medicine
by: Peng‐Fei Wang, et al.
Published: (2025)

CEACAM6 silencing suppresses tumour growth and sensitises cholangiocarcinoma to cisplatin
by: Shi‐Jia Dai, et al.
Published: (2026)

High expression of miR5700 in atypical type A thymoma and its role in promoting tumour progression
by: Li Zhao, et al.
Published: (2026)

scICB: A pan‐cancer database of human temporal immune checkpoint blockade therapy at single‐cell transcriptomic resolution
by: Fansen Ji, et al.
Published: (2025)

The SLC39A1‐DRP1 axis: A paradigm shift in targeting mitochondrial dynamics for HCC therapy
by: Jing Zhao, et al.
Published: (2025)

Sex differences in structural cell‐mediated immune regulation: Implications for precision respiratory medicine
by: Quocdai Vu, et al.
Published: (2026)

Genetic insights into congenital heart disease: Prevalence, aetiology and clinical implications
by: Yuan Yuan, et al.
Published: (2025)

Safety and efficacy of isocitrate dehydrogenase‐1 inhibitor ivosidenib in patients with cholangiocarcinoma
by: Lindsay Wong, et al.
Published: (2026)

Surufatinib plus anti‐PD‐1/PD‐L1 antibody as second‐line therapy for advanced biliary tract cancer: A single‐centre investigator‐initiated trial
by: Xinni Chen, et al.
Published: (2026)

Mechanisms, impacts and therapeutic strategies of glucose metabolic reprogramming in tumours
by: Li Ma, et al.
Published: (2025)

Alveolar IL1β + neutrophils: Emerging biomarkers and therapeutic targets in CARDS progression
by: Lu Jia, et al.
Published: (2025)

Advances in epilepsy associated with 16p11.2 microdeletion syndrome
by: Qikai Zhao, et al.
Published: (2025)

Heterogeneous nuclear ribonucleoprotein A2/B1, a key regulator of myocardial fibrosis
by: Ji‐Hoon Jeong, et al.
Published: (2024)

The emerging role of CAMK1D in diabetes, metabolism and feeding behaviours: A mechanistic systematic review
by: Livio Tarchi, et al.
Published: (2026)

Epigenetic regulation of Epstein–Barr virus: From bench to bedside
by: Xiao Gao, et al.
Published: (2024)

Advancing precision medicine through single‐cell sequencing: Insights and implications
by: Xu Zhang, et al.
Published: (2024)

Platelet volume could predict the efficacy of thrombopoietin receptor agonists in the treatment of patients with primary immune thrombocytopenia
by: Bei Xu, et al.
Published: (2025)

GPR183 ‐mediated activation of PI3K is a potential biomarker for immunotherapy in lung cancer
by: Ling Ye, et al.
Published: (2026)

Anti‐PF4 antibody inhibit proliferation of lung cancer cells without TP53 mutation by inducing apoptosis and cell cycle arrest
by: Mengjia Qian, et al.
Published: (2025)